Xinmei Yang Selected Research

cucurbitacin IIa

1/2020

Synthesis of cucurbitacin IIa derivatives with apoptosis-inducing capabilities in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinmei Yang Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 02/2010
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
3	Carcinogenesis 12/2020 - 01/2016
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2018
2	Pleural Effusion (Pleural Effusions) 06/2018 - 12/2016
2	Lung Neoplasms (Lung Cancer) 12/2016 - 01/2016
1	Adenocarcinoma of Lung 02/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Stomach Neoplasms (Stomach Cancer) 09/2020
1	Adenocarcinoma 10/2019
1	Tuberculosis (Tuberculoses) 06/2018
1	Lymphoma (Lymphomas) 06/2018
1	Candidiasis (Moniliasis) 01/2018
1	Disease Progression 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	racemosin BIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Nifedipine (Adalat)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2021
1	CXC ChemokinesIBA 12/2020
1	Protein Isoforms (Isoforms)IBA 09/2020
1	Biological ProductsIBA 01/2020
1	cucurbitacin IIaIBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Competitive Endogenous RNAIBA 10/2019
1	Adenosine DeaminaseIBA 06/2018
1	Procollagen Type IIBA 01/2018
1	AzolesIBA 01/2018
1	Antifungal AgentsIBA 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2018
1	ORALIT (ORS)IBA 12/2016
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	EnzymesIBA 04/2012
1	Glutathione S-Transferase piIBA 04/2012
1	OxadiazolesIBA 02/2010
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2010
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 02/2010

Therapy/Procedure

2	Chemoradiotherapy 01/2022 - 10/2021
2	Radiotherapy 01/2022 - 10/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Therapeutics 01/2022